<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#Cover" roleURI="http://mosaicie.com/role/Cover" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#BalanceSheets" roleURI="http://mosaicie.com/role/BalanceSheets" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#BalanceSheetsParenthetical" roleURI="http://mosaicie.com/role/BalanceSheetsParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#StatementsOfOperations" roleURI="http://mosaicie.com/role/StatementsOfOperations" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#StatementsOfStockholdersDeficit" roleURI="http://mosaicie.com/role/StatementsOfStockholdersDeficit" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#StatementOfCashFlows" roleURI="http://mosaicie.com/role/StatementOfCashFlows" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#OrganizationAndBusiness" roleURI="http://mosaicie.com/role/OrganizationAndBusiness" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#BasisOfPresentationAndSignificantAccountingPolicies" roleURI="http://mosaicie.com/role/BasisOfPresentationAndSignificantAccountingPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#FairValueOfFinancialInstruments" roleURI="http://mosaicie.com/role/FairValueOfFinancialInstruments" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#AccruedExpensesAndOtherCurrentLiabilities" roleURI="http://mosaicie.com/role/AccruedExpensesAndOtherCurrentLiabilities" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#LicenseAgreements" roleURI="http://mosaicie.com/role/LicenseAgreements" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#ConvertibleNotes" roleURI="http://mosaicie.com/role/ConvertibleNotes" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#NotePayable" roleURI="http://mosaicie.com/role/NotePayable" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#StockholdersEquityAndShare-basedCompensation" roleURI="http://mosaicie.com/role/StockholdersEquityAndShare-basedCompensation" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#CommitmentsAndContingencies" roleURI="http://mosaicie.com/role/CommitmentsAndContingencies" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#RelatedParties" roleURI="http://mosaicie.com/role/RelatedParties" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#OncotelicTherapeuticsInc.Oncotelic" roleURI="http://mosaicie.com/role/OncotelicTherapeuticsInc.Oncotelic" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#SegmentInformation" roleURI="http://mosaicie.com/role/SegmentInformation" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#SubsequentEvents" roleURI="http://mosaicie.com/role/SubsequentEvents" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#BasisOfPresentationAndSignificantAccountingPoliciesPolicies" roleURI="http://mosaicie.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#AccruedExpensesAndOtherCurrentLiabilitiesTables" roleURI="http://mosaicie.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#StockholdersEquityAndShare-basedCompensationTables" roleURI="http://mosaicie.com/role/StockholdersEquityAndShare-basedCompensationTables" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#OrganizationAndBusinessDetailsNarrative" roleURI="http://mosaicie.com/role/OrganizationAndBusinessDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#AccruedExpensesAndOtherCurrentLiabilitiesDetails" roleURI="http://mosaicie.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#AccruedExpensesAndOtherCurrentLiabilitiesDetailsNarrative" roleURI="http://mosaicie.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#LicenseAgreementsDetailsNarrative" roleURI="http://mosaicie.com/role/LicenseAgreementsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#ConvertibleNotesDetailsNarrative" roleURI="http://mosaicie.com/role/ConvertibleNotesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#NotePayableDetailsNarrative" roleURI="http://mosaicie.com/role/NotePayableDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#StockholdersEquityAndShare-basedCompensationDetails-RsuActivity" roleURI="http://mosaicie.com/role/StockholdersEquityAndShare-basedCompensationDetails-RsuActivity" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#StockholdersEquityAndShare-basedCompensationDetailsNarrative" roleURI="http://mosaicie.com/role/StockholdersEquityAndShare-basedCompensationDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#CommitmentsAndContingenciesDetailsNarrative" roleURI="http://mosaicie.com/role/CommitmentsAndContingenciesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#RelatedPartiesDetailsNarrative" roleURI="http://mosaicie.com/role/RelatedPartiesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#OncotelicTherapeuticsInc.OncotelicDetailsNarrative" roleURI="http://mosaicie.com/role/OncotelicTherapeuticsInc.OncotelicDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="cpmv-20260630.xsd#SegmentInformationDetailsNarrative" roleURI="http://mosaicie.com/role/SegmentInformationDetailsNarrative" />
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LoansPayableCurrent" xlink:label="loc_us-gaapLoansPayableCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLoansPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConvertibleDebt" xlink:label="loc_us-gaapConvertibleDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapConvertibleDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="loc_us-gaapOtherNonoperatingIncome" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherNonoperatingIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestAndOtherIncome" xlink:label="loc_us-gaapInterestAndOtherIncome" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestAndOtherIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpenseDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherNoncashExpense" xlink:label="loc_us-gaapOtherNoncashExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherNoncashExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/StatementsOfStockholdersDeficit" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Stockholders&apos; Deficit (Unaudited)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/StatementOfCashFlows" xlink:title="00000006 - Statement - Condensed Consolidated Statement of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherNoncashExpense" xlink:label="loc_us-gaapOtherNoncashExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOtherNoncashExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccruedLiabilities" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/OrganizationAndBusiness" xlink:title="999012 - Disclosure - Organization and Business" />
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/BasisOfPresentationAndSignificantAccountingPolicies" xlink:title="999013 - Disclosure - Basis of Presentation and Significant Accounting Policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/FairValueOfFinancialInstruments" xlink:title="999014 - Disclosure - Fair Value of Financial Instruments" />
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/AccruedExpensesAndOtherCurrentLiabilities" xlink:title="999015 - Disclosure - Accrued Expenses and Other Current Liabilities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/LicenseAgreements" xlink:title="999016 - Disclosure - License Agreements" />
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/ConvertibleNotes" xlink:title="999017 - Disclosure - Convertible Notes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/NotePayable" xlink:title="999018 - Disclosure - Note Payable" />
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/StockholdersEquityAndShare-basedCompensation" xlink:title="999019 - Disclosure - Stockholders&#8217; Equity and Share-Based Compensation" />
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/CommitmentsAndContingencies" xlink:title="999020 - Disclosure - Commitments and Contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/RelatedParties" xlink:title="999021 - Disclosure - Related Parties" />
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/OncotelicTherapeuticsInc.Oncotelic" xlink:title="999022 - Disclosure - Oncotelic Therapeutics, Inc. (&#8220;Oncotelic&#8221;)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/SegmentInformation" xlink:title="999023 - Disclosure - Segment Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/SubsequentEvents" xlink:title="999024 - Disclosure - Subsequent Events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" xlink:title="999025 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:title="999026 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/StockholdersEquityAndShare-basedCompensationTables" xlink:title="999027 - Disclosure - Stockholders&#8217; Equity and Share-Based Compensation (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/OrganizationAndBusinessDetailsNarrative" xlink:title="999028 - Disclosure - Organization and Business (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:title="999029 - Disclosure - Accrued Expenses and Other Current Liabilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetailsNarrative" xlink:title="999030 - Disclosure - Accrued Expenses and Other Current Liabilities (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/LicenseAgreementsDetailsNarrative" xlink:title="999031 - Disclosure - License Agreements (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/ConvertibleNotesDetailsNarrative" xlink:title="999032 - Disclosure - Convertible Notes (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/NotePayableDetailsNarrative" xlink:title="999033 - Disclosure - Note Payable (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/StockholdersEquityAndShare-basedCompensationDetails-RsuActivity" xlink:title="999034 - Disclosure - Stockholders&apos; Equity and Share-Based Compensation (Details - RSU activity)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/StockholdersEquityAndShare-basedCompensationDetailsNarrative" xlink:title="999035 - Disclosure - Stockholders&#8217; Equity and Share-Based Compensation (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="999036 - Disclosure - Commitments and Contingencies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/RelatedPartiesDetailsNarrative" xlink:title="999037 - Disclosure - Related Parties (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/OncotelicTherapeuticsInc.OncotelicDetailsNarrative" xlink:title="999038 - Disclosure - Oncotelic Therapeutics, Inc. (&#8220;Oncotelic&#8221;) (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://mosaicie.com/role/SegmentInformationDetailsNarrative" xlink:title="999039 - Disclosure - Segment Information (Details Narrative)" />
</link:linkbase>
